MOUNTAIN VIEW, Calif., Nov. 3, 2015 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 21st Annual Medical Technologies 2016: A Frost & Sullivan Executive MindXchange is taking place on March 13 to 15, 2016 at the Hilton San Diego Resort & Spa in San Diego, California.
This C-level executive event will feature an array of high-caliber sessions exploring the changes currently occurring in the healthcare industry including transformative new business models, breakthroughs in digital health and the dawn of genomic medicine.
Senior Director, Product Development, Growth and Payer Innovation -- Health & Wellness, Walmart, Alex Hurd will lead the session on Retail Healthcare: The Consumerization of Diagnostic Healthcare.
Session participants will discover:
- Why Walmart is succeeding in retail healthcare
- How their model is sustainable and reduces costs
- How Walmart is improving access and the quality of healthcare
A seasoned panel of venture capitalists will offer their insights on navigating market opportunities on the evolving healthcare landscape during the Investor Spotlight session, Perspectives from The Street and Sand Hill.
This informative panel will examine the following:
- The investments being made in the industry
- Healthcare investments and their value
- The current IPO state
Senior Vice President and Chief Medical Officer, Sequenom, Inc., Daniel S. Grosu; MD, MBA, will present an Executive Bulletin; Medicine at the Dawn of the Genomic Era. He will help participants to prepare for the new era of genomic medicine and join the revolution that is already underway. Grosu will address the rapid technological progress in the field of gene sequencing and the opportunities this has created for novel clinical applications across many unrelated fields.
The scope of the transitions currently occurring in healthcare will be fully explored at the 21st Annual Medical Technologies 2016: A Frost & Sullivan Executive MindXchange.
All participants will benefit from Executive Insight and best practice discussions, as well as a highly interactive and collaborative environment. Expert panel discussions and unique peer-to-peer networking opportunities will round out this dynamic event.
To register and download the event agenda for Medical Technologies 2016: A Frost & Sullivan Executive MindXchange, please visit: www.frost.com/medtech
For additional information, please email: email@example.com or contact Matthew McSweegan at 516-255-3812.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.
Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Corporate Communications – North America
SOURCE Frost & Sullivan